The 1990s were a strange split-screen decade for American cars, with minivans and SUVs taking over driveways while a handful ...

News » DiNAQOR and Academic Partners Launch Paradigm Shift in In Vivo Delivery of Advanced Therapies DiNAQOR and Academic Partners Launch Paradigm Shift in In Vivo Delivery of Advanced Therapies ...

Studienergebnisse DiNAQOR and Academic Partners Launch Paradigm Shift in In Vivo Delivery of Advanced Therapies 23.12.2025 / 14:36 CET/CEST ...

Bipolar Disorder, Digital Phenotyping, Multimodal Learning, Face/Voice/Phone, Mood Classification, Relapse Prediction, T-SNE, Ablation Share and Cite: de Filippis, R. and Al Foysal, A. (2025) ...

Seasoned Biotech Entrepreneur Dr. Christian Thirion Appointed CEO of DiNATEQ AG and Group Chief Strategy & Business Development Officer; Dr. Josef El Andari Named Chief Scientific Officer of DiNAQOR ...

X-linked retinoschisis gene replacement therapy, aiming to improve retinal architecture and visual function in young male ...

Alphabet stock has rallied roughly 48% since Sept. 1, leading to a 60.5% year-to-date gain. Priced north of $300 per share, ...

LLVision will debut Leion Hey2, the world's first purpose-built AI-powered AR translation glasses, at CES 2026 ...

Leishmaniasis remains a major neglected tropical disease in humans, driven by diverse Leishmania species transmitted by sand ...

AI initiatives don’t stall because models aren’t good enough, but because data architecture lags the requirements of agentic systems.

With AI’s power demands intensifying, SSDs are primed to overtake HDDs as the default choice for maximizing performance, ...

Authors explore complexities in scaling gene-therapy production with special attention is to monitoring and enhancing ...